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Abstract 
BACKGROUND: Melasma is a common chronic acquired hyper melanosis. It has significant impacts on 
appearance, psychosocial and emotional distress, hence reducing the quality of life of the affected patients. 
Melasma quality of life scale (MelasQoL) is a new quality of life (QoL) questionnaire consists of 10 questions, 
scored from 1 to 7, with higher index scores indicating poor QoL. The severity of melasma can be assessed by 
the Melasma Area and Severity Index (MASI) score. 
AIM:  We aimed to determine the correlation between the severity of melasma (MASI score) and quality of life. 
MATERIAL AND METHODS: This was a cross-sectional analytic study involving 30 subjects with melasma. The 
diagnosis was made based on history, clinical features and by Wood’s lamp examination. MASI score was 
determined to assess the severity of melasma. Subjects answered 10 items of MelasQol questionnaire. All 
collected data were processed and statistically analysed by Spearman correlation test to determine the 
association of MASI score with MelasQoL. Association of quality of life with clinical pattern and depth of lesion 
were analysed by Mann Whitney test. 
RESULTS: There was no significant correlation between MASI score and MelasQoL (p = 0.797; r = 0.049). 
Likewise, there was no association of quality of life with clinical pattern type (p = 0.12) and depth of lesion (p = 
0.92). 
CONCLUSION: There was no significant correlation between the MASI score and quality of life. 
 
 
 
 
Introduction 
 
Melasma is acquired dermatological disease 
characterised by light to dark brown 
hyperpigmentation with predilection on ultraviolet (UV) 
exposed area, especially the face. Although its 
pathogenesis is not yet clearly defined, some 
aetiology factors have been identified, including UV 
exposure, hormones, drugs, genetics, races and 
cosmetics ingredients [1]. 
Treatment of melasma until now is still a 
problem so that often causing desperation for those 
who have it. Melasma is a skin problem that affects 
the appearance of facial skin aesthetically and can 
reduce the confidence of a person so that it can cause 
low quality of life of the patient. 
Quality of life is a very important issue in 
psychological health. Measurement quality of life can 
use the questionnaire contains factors that are 
affecting the quality of life. The melasma quality of life 
scale (MelasQoL) is a new QoL questionnaire 
developed and validated by Balkrishnan in 2003. It 
consists of 10 questions, scored from 1 to 7, with 
higher index scores indicating worse QoL [2]. 
 
 
Material and Methods 
 
This is an observational analytic study with 
cross-sectional approach. This research has been 
conducted from February to August 2017, located in 
General Hospital Universitas Sumatera Utara, Medan, 
Indonesia involving 30 subjects with melasma. The 
diagnosis was made based on history, clinical 
features and by Wood’s lamp examination. MASI 
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score was determined to assess the severity of 
melasma with a score range between 0-48. The MASI 
score is calculated by a subjective assessment of 3 
factors. Area (A) of involvement, darkness (D), and 
homogeneity (H), with the forehead (f), right malar 
region (rm), left malar region (lm), and chin (c), 
corresponding to 30%, 30%, 30%. And 10% of the 
total face, respectively 
The area of involvement in each of these 4 
areas is given a numeric value of 0 to 6 (0 = no 
involvement; 1 = < 10%, 2 = 10%; 29%; 3 = 30%-
49%; 4 = 50-69%; 5 = 70%-89%, and 6 = 90%-100%). 
 Darknessn and homogeneity, are rated on a 
scale from 0 to 4 (0 = absent, 1 = slight; 2 = mild; 3 = 
marked; and 4 = maximum). The MASI score is 
calculated by adding the sum of the severity ratings 
for darkness and homogeneity, multiplied by the value 
of the area of involvement, for each of the 4 facial 
areas: 
MASI total score = 0.3A (f) [D(f) + H(f)] 
+0.3A (lm) [D(lm) + H (lm)] 
+0.3A (rm) [D(rm) + H (rm)] 
+0.1A (c) [D(c) + H(c)] 
Subjects answered 10 items MelasQol with 
total scale range between 1-70 which higher index 
scores indicating worse QOL. 
 
Statistical Analysis 
All collected data were processed and 
statistically analysed by Spearman correlation test to 
determine the association of MASI score with quality 
of life. Association of quality of life with clinical pattern 
and depth of lesion were analysed by Mann Whitney 
test. 
 
 
Results 
 
The mean age group found in this study was 
39.3 ± 4.7. Distribution of melasma based on clinical 
pattern type and depth of lesion assessed by Wood’s 
lamp was presented in Table 1. The mean of MASI 
score was 13,07 ± 4,99, and the mean of MelasQol 
was 39,97 ± 12,07.  
Table 1: Distribution of melasma based on clinical pattern and 
depth of the lesion 
Characteristics n Percentage (%) 
Clinical pattern   
Centrofacial 19 63.3 
Malar 11 36.7 
Mandibular 0 0 
Depth of lesion   
Epidermal 27 90 
Dermal 3 10 
Mixed 0 0 
Unclear  0 0 
 
Table 2 shows that there was no significant 
relationship between MASI score with quality of life (p 
> 0.05). 
Table 2: The association between MASI score and quality of life 
in subject with melasma 
 p r 
MASI score with Quality of life 0.797 0.04 
 
Table 3 shows that quality of life was slightly 
higher in dentofacial subject type (42.6 ± 13.7). 
Epidermal type of melasma was higher QOL than 
dermal (40.0 ± 12.1).  
Table 3: The association between quality of life with the type of 
clinical pattern and depth of lesion in subject with melasma 
 n Mean SD p 
Clinical Pattern type     
Centrofacial 19 42.6 ± 13.7  
Malar 11 35.5 ± 7.1 0.12 
Mandibular 0 0 0  
Depth of Lesion type     
Epidermal 27 40.0 ± 12.1  
Dermal 3 39.3 ± 13.5 0.92 
Mixed 0 0 0  
Unclear 0 0 0  
 
There was statistically no significant with p > 
0.05 (p-value 0.12 and 0.92) for all of those 
association. 
 
 
Discussion 
 
In this study, the mean age group was 39.3 ± 
4.7. It is consistent with a study by Jusuf in General 
Hospital of Haji Adam Malik Medan Cosmetic 
Dermatology Clinic which showed that pigmentation 
disorders including melasma from the year 2012-2014 
were mostly affecting people between 38-48 years 
old. Most melasma occurs in women of reproductive 
age.3 In general, dentofacial type is the most common 
type, which is 63% covering the forehead area, nose, 
medial cheeks, under the nose and chin.1 This study 
is similar with Krupashankar et al., which found 45% 
proportion of dentofacial type4 and also Guinot et al., 
which showed 76% of centrofacial type [5]. 
Mahdalena et al., also found that centrofacial type is 
the most common type in 52,9%.6 Different results 
were concluded by Jagannathan et el that found a 
malar type of 65%.7 On Wood’s lamp examination, 
the epidermal type was found in 27 persons (90%). 
This study is consistent with Jagannathan et al., and 
Mahdalena et al., that obtained the epidermal type in 
94.1% and 48.75%, respectively [6], [7]. Wood’s lamp 
with wavelength 320-450 nm can be used to 
determine melanin in the skin. On examination with 
Wood's lamp, the epidermal type of melasma will 
appear more clearly than using ordinary room 
lightings [8]. 
In this research, the mean of MASI score was 
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13.07 ± 4.99 with majority showed middle range in the 
severity of melasma. While the mean of MelasQol was 
39.97 ± 12.07 which is showed the middle range of 
total MelasQol scale. Melasma is distressing to 
patients due to its location, appearance and 
accompanying disfiguring lesions. The clinical 
evaluation alone is not sufficient to describe the 
feelings experienced by the patient. Questionnaires 
are useful to understand better the feelings of the 
patient, and the impacts of the disease on different 
aspects of life. The MelasQoL scale has more focus 
on the emotional and psychosocial impact of the 
condition [2]. 
In Table 1, it appears that there is no 
statistical relationship between MASI score with 
quality of life in subjects with melasma. Similarly, 
Harumi et al., in Singapore, found there was no 
correlation between MASI scores with MelasQol or 
DLQI scores [9]. Freitag at al., research in southern 
Brazil show there was no correlation between 
MelasQol and MASI scores [10]. It shows and 
corroborating that clinical severity is not the sole 
criterion used by patients to assess the impairment 
caused by their skin condition. Different results were 
concluded by Cestari et al., the analysis of the 
MelasQoL baseline answers demonstrated an 
important impact of the disease on skin appearance 
(65% of patients were bothered all the time or most of 
the time), frustration (55%), embarrassment (57%) 
and influence of the disease on interpersonal 
relationships (42%). Forty-three per cent of patients 
felt not attractive or even dirty due to their skin 
condition. MelasQoL results showed significant 
internal consistency and good correlation with MASI 
scores [11]. Balkrishnan et al. show the correlations 
among different scales used in the study. The 
MelasQol scores are highly correlated with the other 
dermatology QoL scores and are moderately 
correlated with the MASI [2]. Misery et al. found that 
the Melas Qol score was found to be higher in women 
over 45 years of age and in women who had had 
melasma for longer, suggesting that the condition is 
not better accepted by women with time [12]. 
Histologically, melasma lesion showed an 
increased number of melanocytes with additional 
melanin deposition, usually on the cheeks, forehead, 
and upper lip [13]. In our study, the mean MelasQol 
scores were higher in subject with dentofacial type 
and were slightly higher in the epidermal type, but 
statistically were not significant. Based on the clinical 
pattern and depth of the lesion, the type of melasma 
still affected the quality of life of the subject, although 
not significant. 
The fact that melasma is a chronic recurrent 
disorder that burst during their entire life leads to an 
increased possibility of unwanted outcomes. This 
research no significant correlation between the 
severity of melasma and quality of life. The physician 
may erroneously consider a patient as having a mild 
form of the disease, whereas she might be upset, 
anxious and considers that her lesions cause a 
significant impact or her life. It means that therapeutic 
decisions cannot be based only on clinical aspects but 
should also include their psychological characteristics 
[14]. Thus, the quality of life in melasma has emerged 
as an important outcome of clinical investigation and 
should be assessed as far as possible [15]. 
In conclusion, there was no significant 
correlation between the severity of melasma and 
quality of life. It needs to encourage multi audience 
study to develop more studies about quality of life in 
larger populations. 
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